medigraphic.com
ISSN 1561-302X (Print)

2022, Number 4

<< Back Next >>

Rev cubana med 2022; 61 (4)

Factors related to lethality in exacerbated chronic obstructive pulmonary disease

Elías SR, Elías AKS, Choo UT, Bordelois AMS

Language: Spanish
References: 19
Page: 1-11
PDF size: 572.75 Kb.


ABSTRACT

Introduction: The lethality of exacerbated chronic obstructive pulmonary disease is an unresolved problem in intensive care units.
Objective: To identify the factors related to the lethality of patients with exacerbation of chronic obstructive pulmonary disease, discharged from the intensive care unit in the Dr. “Agostinho Netoˮ Hospital of Guantánamo, from 2019 to 2020.
Methods: A case-control study was carried out using sociodemographic variables (age, gender, nutritional status, comorbidity, toxic habits), and other variables related to chronic obstructive pulmonary disease (phenotype, severity, associated diagnoses, gasometric indicators, treatment with mechanical ventilation, complications, status at discharge, causes of death).
Results: The largest number of patients were characterized by: being over 60 years old (n=45), male (n=46), with more than 10 years of disease evolution (n=37), underweight (n=35), and three or more comorbidities (n=41) and the most common was chronic pulmonary heart (n=36), high Sequential Organ Failure Assessment Score and Acute Physiology and Chronic Health Evaluation II), smokers (n=47), among other aspects.
Conclusions: The factors most associated with lethality were Sequential Organ Failure Assessment Score) score equal to or greater than 16 points, hypoxemia equal to or greater than 60 mmHg, and performance of tracheostomy 5 or more days of mechanical ventilation.


REFERENCES

  1. World Health Organization. Enfermedad pulmonar obstructiva (EPOC). 2020. [acceso: 15/07/2021]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)1.

  2. Medina OCM. Enfermedad pulmonar obstructiva crónica. Un desafío en el nuevo milenio. Rev. Méd Electrón. 2007 [acceso: 15/07/2021];29(1):8. Disponible en: Disponible en: http://www.cpimtz.sld.cu/revista medica/año 202007/vol1202007/tema09.htmL 2.

  3. Global strategy for prevention, diagnosis and management of COPD: Global Strategy for Prevention, Diagnosis and Management of COPD (2018 Report). 2018 [acceso: 15/07/2021];56(4):42 Disponible en: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-final-revised-20-nov_wms.pdf3.

  4. Despaigne SR, Benítez SE, Pérez NG, Corujo LO, Acosta AN. Factores pronósticos de letalidad en pacientes con enfermedad pulmonar obstructiva crónica en cuidados intensivos. Rev Cub Med Mil. 2018 [acceso: 15/07/2021];47(3):231-43. Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/1524.

  5. Grupo de trabajo of GesEPOC. Task Force. Guía de práctica clínica para el diagnóstico y tratamiento de pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC)-Guía Española de la EPOC (GesEPOC). Arch Bronconeumol. 2012 [acceso: 15/07/2021];48(Supl 1):2-58. Disponible en: https://www.archbronconeumol.org/es-guia-practica-clinica-el-diagnostico-articulo-resumen-S03002896127003525.

  6. Global initiative for chronic obstructive lung disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary. 2017 [acceso: 15/07/2021];42(8):98-104. Disponible en: http://www.goldcopd.org6.

  7. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581-6. DOI: http://dx.doi.org/10.1136/thx.54.7.5817.

  8. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2017 [acceso: 15/07/2021];56(4):30. Disponible en: http://goldcopd.org8.

  9. Soler CJJ, Cosio B, Izquierdo JL, López CJL, Marin JM, Agüero R, et al. Documento de consenso sobre el fenotipo mixto EPOC-asma en la EPOC. Arch Bronconeumol. 2012 [acceso: 15/07/2021];48(9):331-9. Disponible en: Disponible en: https://www.archbronconeumol.org/es-documento-consenso-sobre-el-fenotipo-articulo-S0300289612000087 9.

  10. Asociación Médica Mundial. Principios éticos para las investigaciones médicas en seres humanos. Declaración de Helsinki. Finlandia; 1964.

  11. González RR, Barcón DL. Caracterización clínico-epidemiológica de pacientes con enfermedad pulmonar obstructiva crónica reagudizada. Rev. Arch Med Camagüey. 2018 [acceso: 15/07/2021]; 22(3):292-302. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552018000300005&lng=es11.

  12. Echazarreta AL, Arias SJ, del Olmo R, Giugno ER, Colodenco FD, Arce SC, et al. Prevalencia de enfermedad pulmonar obstructiva crónica en 6 aglomerados urbanos de Argentina: el estudio EPOC. Arch Bronconeumol. 2017;54(5):260-9. DOI: https://doi.org/10.1016/j.arbres.2017.09.01812.

  13. García GS, Carazo FL, García JJ, Naveiro RJC. Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC. Aten Prim. 2017;49(10):603-10. DOI: http://dx.doi.org/10.1016/aprim.2017.01.0013.

  14. García SMT, González BFJ. Establecer el pronóstico de la agudización de EPOC mediante el uso de escalas de riesgo: punto de vista del servicio de urgencias Arch bronconeumol. 2020 [acceso: 15/07/2021];56(2):63-4 Disponible en: https://dialnet.unirioja.es/servlet/revista?codigo=292614.

  15. Almagro P, Joan B. Soriano Francisco J. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: The CODEX Index. Chest. 2020;145(5):972-82. DOI: http://dx.doi.org/10.1378/chest.13-132815.

  16. Cabezas PE, Giménez VA, Ortiz MH, Calzado LR, Pérez WMT, Sánchez MD, et al. Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients. European Respiratory Journal. 2016;48: PA4054. DOI: https://doi.org/10.1183/13993003.congress-2016.PA405416.

  17. Guía de práctica clínica basada en la evidencia para la prevención, diagnóstico, tratamiento y seguimiento de la Enfermedad Pulmonar Obstructiva Crónica (EPOC) en población adulta. 2020 [acceso: 15/07/2021];25. Disponible en: http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Conv_563/GPC_epoc/gpc_epoc.aspx17.

  18. Greening NJ, Williams JE, Hussain SF, Harvey Dunstan TC, Bankart MJ, Chaplin EJ. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomized controlled trial. BMJ. 2020 [acceso: 15/07/2021];8(349):5. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/2500491718.

  19. Folch AA, Orts CMI, Macia SL, Andreu GMV, Moncho J. Patient education during hospital admission due to exacerbation of chronic obstructive pulmonary disease: Effects on quality of life - Controlled and randomized experimental study. Patient Educ Couns. 2018;102(3):511-9. DOI: https://doi.org/10.1016/j.pec.2018.09.01319.




2020     |     www.medigraphic.com